Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Immucor has confirmed variable weak reactivity of the js(a) antigen on cell 2 (donor b5415) of panocell-16 (lot 52107). this has resulted in unexpected weak and negative reactions when testing this cell with various examples of anti-jsa during the shelf life of the product.